|
1) Takano H, Qin Y, Hasegawa H, et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med. 2006; 84: 185-93
|
|
|
|
2) Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001; 98: 10344-9
|
|
|
|
|
3) Ohtsuka M, Takano H, Zou Y, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 2004; 18: 851-3
|
|
|
|
|
|
4) Minatoguchi S, Takemura G, Chen XH, et al. Acceleration of the healing process and myocar-dial regeneration may be important as a mecha-nism of improvement of cardiac function and re-modeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation. 2004; 109: 2572-80
|
|
|
|
|
|
5) Miki T, Miura T, Nishino Y, et al. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin Exp Pharmacol Physiol. 2004; 31: 873-82
|
|
|
|
|
|
6) Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005; 65: 446-56
|
|
|
|
|
|
7) Kawada H, Fujita J, Kinjo K, et al. Nonhema-topoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004; 104: 3581-7
|
|
|
|
|
|
8) Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005; 11: 305-11
|
|
|
|
|
|
9) Iwanaga K, Takano H, Ohtsuka M, et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun. 2004; 325: 1353-9
|
|
|
|
|
|
10) Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulat-ing factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet. 2004; 363: 751-6
|
|
|
|
|
|
11) Hill JM, Syed MA, Arai AE, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol. 2005; 46: 1643-8
|
|
|
|
|
|
12) Yoshioka T, Takahashi M, Shiba Y, et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res. 2006; 70: 61-9
|
|
|
|
|
|
13) Takamiya M, Okigaki M, Jin D, et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit＋/Flk-1＋ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2006; 26: 751-7
|
|
|
|
|
|
14) Hasegawa H, Takano H, Ohtsuka M, et al. G-CSF prevents the progression of atherosclerosis and neointimal formation in rabbits. Biochem Biophys Res Commun. 2006; 344: 370-6
|
|
|
|
|
|
15) Cho HJ, Kim TY, Cho HJ, et al. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol. 2006; 48: 366-74
|
|
|
|
|
|
16) Lim SY, Kim YS, Ahn Y, et al. The effects of granulocyte-colony stimulating factor in bare stent and sirolimus-eluting stent in pigs following myocardial infarction. Int J Cardiol. 2007; 118: 304-11
|
|
|
|
|
|
17) Kuethe F, Figulla HR, Herzau M, et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. Am Heart J. 2005; 150: 115 (e1-7)
|
|
|
|
|
|
18) Valgimigli M, Rigolin GM, Cittanti C, et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J. 2005; 26: 1838-45
|
|
|
|
|
|
19) Ince H, Petzsch M, Kleine HD, et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation. 2005; 112: 3097-106
|
|
|
|
|
|
20) Zohlnhofer D, Ott I, Mehilli J, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarc-tion: a randomized controlled trial. JAMA. 2006; 295: 1003-10
|
|
|
|
|
|
21) Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1210-21
|
|
|
|
|
|
22) Ripa RS, Jorgensen E, Wang Y, et al. Stem cell mobilization induced by subcutaneous granulo-cyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, rando-mized, placebo-controlled stem cells in myocar-dial infarction (STEMMI) trial. Circulation. 2006; 113: 1983-92
|
|
|
|
|
|
23) Takano H, Hasegawa H, Kuwabara Y, et al. Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol. 2007; 122: 41-7
|
|
|
|
|
|
24) Engelmann MG, Theiss HD, Hennig-Theiss C, et al. Autologous bone marrow stem cell mobiliza-tion induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myo-cardial infarction undergoing late revascu-larization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2006; 48: 1712-21
|
|
|
|
|
|
25) Takano H, Ueda K, Hasegawa H, et al. G-CSF therapy for acute myocardial infarction. Trends Pharmacol Sci. 2007; 28: 512-7
|
|
|
|
|